Back to Journals » Vascular Health and Risk Management » Volume 3 » Issue 2

ESCI
SJR OA
CiteScore
Impact Factor

ISSN: 1178-2048


       

Archive: Volume 3, 2007


Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial

Przemyslaw Kardas

Vascular Health and Risk Management 2007, 3:235-242

Published Date: 15 May 2007

Epidemiology, classification, and modifiable risk factors of peripheral arterial disease

Nicolas W Shammas

Vascular Health and Risk Management 2007, 3:229-234

Published Date: 15 May 2007

Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome

Caroline Schmidt-Lucke, Heinz-Peter Schultheiss

Vascular Health and Risk Management 2007, 3:221-228

Published Date: 15 May 2007

Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination

Andreas Pfützner, Birgit Wilhelm, Thomas Forst

Vascular Health and Risk Management 2007, 3:211-220

Published Date: 15 May 2007

Review of sitagliptin phosphate: a novel treatment for type 2 diabetes

Baptist Gallwitz

Vascular Health and Risk Management 2007, 3:203-210

Published Date: 15 May 2007

Sirolimus-eluting coronary stents: a review

Alexandre Abizaid

Vascular Health and Risk Management 2007, 3:191-201

Published Date: 15 May 2007

Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data

Kirk A Bronander, Michael J Bloch

Vascular Health and Risk Management 2007, 3:181-190

Published Date: 15 May 2007